GMRE:NYE-Global Medical REIT Inc. (USD)

EQUITY | REIT - Healthcare Facilities | New York Stock Exchange

Last Closing

USD 8.88

Change

-0.06 (-0.67)%

Market Cap

USD 0.13B

Volume

0.34M

Analyst Target

USD 14.79
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Global Medical REIT Inc owns, operates, develops and manages specialty medical properties including medical office buildings, outpatient treatment & diagnostic facilities, physical group practice clinics, ambulatory surgery centers and treatment centers.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-21 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

+0.17 (+0.16%)

USD 62.07B
VTR Ventas Inc

+0.06 (+0.12%)

USD 20.25B
DOC Healthpeak Properties Inc

+0.08 (+0.41%)

USD 13.74B
OHI Omega Healthcare Investors Inc

+0.26 (+0.81%)

USD 8.34B
HR Healthcare Realty Trust Incorp..

-0.04 (-0.24%)

USD 6.33B
CTRE CareTrust REIT Inc.

-0.11 (-0.44%)

USD 3.67B
MPW Medical Properties Trust Inc

+0.02 (+0.41%)

USD 2.96B
NHI National Health Investors Inc

+0.45 (+0.68%)

USD 2.92B
AHR American Healthcare REIT Inc

-0.13 (-0.88%)

USD 1.77B
LTC LTC Properties Inc

-0.27 (-0.80%)

USD 1.50B

ETFs Containing GMRE

KBWY Invesco KBW Premium Yield.. 4.16 % 0.35 %

-0.09 (0%)

USD 0.19B
SDEF 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -20.00% 7% C- 7% C-
Dividend Return 1.89% 50% F 68% D+
Total Return -18.11% 7% C- 8% B-
Trailing 12 Months  
Capital Gain 2.54% 43% F 34% F
Dividend Return 9.70% 100% F 92% A
Total Return 12.24% 43% F 46% F
Trailing 5 Years  
Capital Gain -18.16% 58% F 25% F
Dividend Return 37.88% 100% F 91% A-
Total Return 19.72% 67% D+ 43% F
Average Annual (5 Year Horizon)  
Capital Gain -1.98% 67% D+ 30% F
Dividend Return 4.68% 73% C 48% F
Total Return 6.66% 80% B- 88% B+
Risk Return Profile  
Volatility (Standard Deviation) 25.58% 27% F 44% F
Risk Adjusted Return 18.28% 73% C 40% F
Market Capitalization 0.13B 27% F 48% F

Key Financial Ratios

  Ratio vs. Industry/Classification (REIT - Healthcare Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 38.65 50% 17%
Price/Book Ratio 1.07 86% 68%
Price / Cash Flow Ratio 9.17 87% 41%
Price/Free Cash Flow Ratio 11.09 93% 38%
Management Effectiveness  
Return on Equity 3.57% 47% 36%
Return on Invested Capital 4.16% 53% 40%
Return on Assets 1.77% 40% 41%
Debt to Equity Ratio 4.44% 93% 90%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.